The objective of the present study was to investigate the feasibility of a
DNA vaccine to protect chickens against infectious bursal disease virus (IB
DV) infection, A plasmid DNA carrying VP2, VP4, and VP3 genes of the standa
rd challenge (STC) strain of IBDV was constructed and designated as pCR3.1-
VP243-STC. One-day-old chickens were intramuscularly injected with the plas
mid pCR3.1-VP243-STC once (group D1). twice (group D2), or three times (gro
up D3) at weekly intervals. Chickens at 3 weeks old were orally inoculated
with IBDV strain STC and observed for 10 days after challenge. Immunization
twice (group D2) or three times (group 133) with the plasmid pCR3.1-VP243-
STC conferred protection for 50-100 or 80-100% of chickens, respectively, a
s evidenced by the absence of clinical signs, mortality. and bursal atrophy
. Although chickens vaccinated once (group D1) with the plasmid pCR3.1-VP24
3-STC did not have clinical signs. they exhibited varying degree of bursal
atrophy after challenge. Enzyme-linked immunosorbent assay (ELISA) antibody
titers in chickens protected by the plasmid pCR3.1-VP243-STC were signific
antly lower (P < 0.05) than those not protected 10 days after challenge. IB
DV antigen was not detected in the bursae of chickens that were protected b
y receiving the plasmid pCR3.1-VP243-STC twice or three times. The results
indicate that the constructed plasmid pCR3.1-VP243-STC as a DNA vaccine pro
vided efficacious protection for chickens against IBDV infection. (C) 2001
Elsevier Science Ltd. All rights reserved.